Cary Street Partners Investment Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169K | Buy |
2,446
+320
| +15% | +$22.1K | 0.08% | 270 |
|
|
2025
Q1 | $148K | Buy |
2,126
+1,091
| +105% | +$75.8K | 0.09% | 256 |
|
|
2024
Q4 | $89K | Sell |
1,035
-4,813
| -82% | -$414K | 0.06% | 268 |
|
|
2024
Q3 | $696K | Buy |
5,848
+915
| +19% | +$109K | 0.03% | 428 |
|
|
2024
Q2 | $704K | Buy |
4,933
+289
| +6% | +$41.2K | 0.03% | 393 |
|
|
2024
Q1 | $596K | Buy |
4,644
+663
| +17% | +$85.1K | 0.03% | 422 |
|
|
2023
Q4 | $412K | Buy |
3,981
+204
| +5% | +$21.1K | 0.02% | 456 |
|
|
2023
Q3 | $343K | Buy |
3,777
+3
| +0.1% | +$273 | 0.02% | 454 |
|
|
2023
Q2 | $305K | Sell |
3,774
-32
| -0.8% | -$2.59K | 0.02% | 436 |
|
|
2023
Q1 | $303K | Sell |
3,806
-48
| -1% | -$3.82K | 0.02% | 406 |
|
|
2022
Q4 | $261K | Buy |
+3,854
| New | +$261K | 0.02% | 424 |
|
|
2022
Q3 | – | Sell |
-3,394
| Closed | -$189K | – | 545 |
|
|
2022
Q2 | $189K | Buy |
+3,394
| New | +$189K | 0.02% | 427 |
|